Back to search

Symbiotec Ltd

12027814

active
ltd
england wales
Companies House
Confirmation statement overdue
Health Score
53 / 100

Notable Risks

15/30
Filing
0/30
Financial
38/40
Risk
  • Confirmation statement overdue (-10)
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)
  • 1 outstanding charge (-2)

Details

3rd Floor 86 - 90 Paul Street, London, EC2A 4NE
Incorporated 03/06/2019

Compliance

Last accounts

31/12/2024

total exemption full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 02/06/2026

Due 16/06/2027

On track

Industry

46190
Agents involved in the sale of a variety of goods
72110
Research and experimental development on biotechnology

Officers

Mr Paul Michael Gilligan

director · Since 03/06/2019

DIRECTOR

BRITISH · ENGLAND · Age 55

Also on 7 other boards

Paul Michael Gilligan

director · Since 03/06/2019

British · England · Age 55

Ryszard Adam Bublik

director · Since 02/05/2024

British · England · Age 56

Former

Lisa-Marie Hayes

director · Resigned 11/08/2023

Oliver Benjamin Boyd

director · Resigned 22/12/2023

Emma Jane Brogi

director · Resigned 22/12/2023

Andrew Charles Crimmings

director · Resigned 22/12/2023

Robert Allen

director · Resigned 02/05/2024

Mr Ryszard Adam Bublik

director · Resigned 03/06/2026

Persons with Significant Control

Mmc Holding International Ltd

75–100% shares
75–100% votes
Appoint directors

3rd Floor, 86 - 90 Paul Street, London, EC2A 4NE

Reg: 12977802 · Companies House · Private Limited Company

Notified 11/12/2020

Former PSCs

Mr Oliver Benjamin Boyd

Ceased 11/12/2020

Miss Emma Jane Brogi

Ceased 11/12/2020

Mr Paul Gilligan

Ceased 11/12/2020

Charges1 outstanding

Charge
outstanding

INNOVATEUK LOANS LIMITED

Created 25/07/2023Registered 25/07/2023

Change History

statusactive
2026-06-25

Active

typeltd
2026-06-25

Private Limited Company

address line13rd Floor 86 - 90 Paul Street
2026-06-25

3RD FLOOR

post townLondon
2026-06-25

LONDON

CompanyRankvs 11262+ SIC 46190 peers
9

Financial strength0th percentile among SIC peers · 0/25
Employees100th percentile among SIC peers · 15/15
LiquidityCurrent ratio 0.19× · 2/20
Longevity7 years trading (max 15) · 7/15
Filing complianceOne filing overdue · 5/15
Going concern doubt -10Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance5/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

labour efficiency and capacity are completed, with the objective of moving the trading entities, including Symbiotec Ltd, towards profitability during 2026. The company's ability to continue as a going concern is, however, dependent on the successful delivery of these operational improvements, the conversion of its sales pipeline into profitable contracts, the continued availability of funding

Key FinancialsYear ending 31/12/2024

Net Worth

-£7.0M

Balance sheet strength

Cash

£3k

Cash in the bank

Net Current Assets

-£7.5M

Working capital

Current Assets

£1.7M

Current Liabilities

£9.3M

Fixed Assets

£511k

Debtors

£1.4M

32avg. employees-5

Balance Sheet

Intangible assets£4k
Assets less current liabilities-£7.0M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20240.19-£1.7M
20230.18

Derived from filed accounts. Not audited figures.